Phase 3 Staphylococcus Aureus Clinical Trials
3 recruitingPhase 3
What is a Phase 3 trial?
Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.
Showing 1–3 of 3 trials
Recruiting
Phase 3
Adjunctive Rifampin for the Treatment of Prosthetic Valve Endocarditis Due to S. Aureus
Prosthetic Valve EndocarditisStaphylococcus Aureus Endocarditis
Todd C. Lee MD MPH FIDSA330 enrolled1 locationNCT07253688
Recruiting
Phase 3
Early Intravenous to Oral Antibiotic Switch in Uncomplicated Staphylococcus Aureus Bacteraemia
Staphylococcus Aureus Bacteremia
Clinical Research Centre, Malaysia290 enrolled12 locationsNCT06336824
Completed
Phase 3Phase 4
Fiji Northern Division Ivermectin Mass Drug Administration for Scabies Trial
Post streptococcal glomerulonephritisInvasive group A streptococcal infectionsSkin and soft tissue infections+3 more
Murdoch Children's Research Insititute135,000 enrolled1 locationACTRN12618000461291